ACE inhibitor use and the increased long-term risk of renal failure in diabetes [14]

Kidney International

Volumn 70, Issue 7, 2006, Pages 1377-1378

  Hamming, I ^a   Van Goor, H ^a   Navis, G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DIABETES MELLITUS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SODIUM RESTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PROTEINURIA; RATS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748939747     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001684     Document Type: Letter

References (3)

1. Suissa S, Hutchinson T, Brophy JM et al. ACE-inhibitor use and the long-term risk of renal failure in diabetes. Kidney Int 2006; 69: 913-919.
2. Hamming I, Navis G, Kocks M et al. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J Pathol 2006; 209: 129-139.
3. Smit-van Oosten A, Navis G, Stegeman CA et al. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation. J Pathol 2001; 194: 122-129.